SEC Form 4 · accession 0001140361-15-038703

ORAMED PHARMACEUTICALS INC. · ORMP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Oct 23, 2015

Accepted (ET)

Oct 27, 2015 · 6:37 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001176309

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	holding	—	—		—	896,364	I	By Regals Fund LP

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Call Option (Right to Buy)^F1	$10.00	Oct 23, 2015	P	1,103	A	Oct 23, 2015	May 20, 2016	Common Stock	110,300	2,906	I
Call Option (Right to Buy)^F1	$10.00	Oct 27, 2015	P	1,000	A	Oct 27, 2015	May 20, 2016	Common Stock	100,000	3,906	I
Call Option (Right to Buy)^F1	$10.00	Oct 27, 2015	P	359	A	Oct 27, 2015	May 20, 2016	Common Stock	35,900	4,265	I

F1This Form 4 is filed jointly by Regals Fund LP (the "Fund"), Regals Capital Management LP ("Regals Management"), and David M. Slager (collectively, the "Reporting Persons"). Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The securities reported herein are held for the account of the Fund. Accordingly, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.